A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction
Status:
Completed
Trial end date:
2020-02-26
Target enrollment:
Participant gender:
Summary
This study assesses whether the addition of chemodenervation to an established regimen of
pelvic floor physical therapy for painful high tone pelvic floor dysfunction improves
patients' objective and subjective outcomes. Study subjects will select one of three
treatment approaches: injection of 50 units Botulinum toxin A with local sedation as an
office procedure, injection of 100u BoNTA-cosmetic in either the office or while
anesthetized, or injection of 150 units Botulinum toxin A while anesthetized.
Phase:
Phase 4
Details
Lead Sponsor:
EvergreenHealth
Collaborator:
The Cleveland Clinic
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A